Spotlight on JLABS

Add this event to your calendar:
06/09/2017 13:30 06/09/2017 15:00 America/Los_Angeles Spotlight on JLABS JLABS , 3210 Merryfield Row , San Diego , California JLABS San Diego together with Janssen R&D false DD/MM/YYYY

Spotlight on JLABS

JLABS , 3210 Merryfield Row , San Diego , California

September 06, 2017 from 13:30 PM to 15:00 PM (PST)

$10 - $35

Interested in starting a company, investing, or just curious about the current state of innovation in San Diego? Then YOU are invited to JLABS on September 6th to meet, greet, and see short presentations on some of our standout companies. Space is limited, so don't miss out!

Did you know that JLABS San Diego is home to nearly 50 emerging companies? On September 6th, JLABS will shine the spotlight on four of our resident companies: AimRx, Chime, and Lin Bioscience. Join us to see how they're moving innovation forward, right here in San Diego.

Please note that the presentations at this event will include publicly available, non-confidential information only.

Wednesday, September 6, 2017

11:30am | Lunch
12:00pm | Presentations
1:00pm | Program Close

Presenting Companies:
Chime read more»
AimRx / EpicentRx read more»
Lin Bioscience read more»

Please RSVP online so that we can get an accurate headcount for food and beverages. We will not be accepting walk-ups once the event is sold out.

3210 Merryfield Row
San Diego, CA

Presenting Companies' Descriptions:

CHIME BioTherapeutics, Inc. is an immuno-oncology company focused on the development of innovative cancer immunotherapies based on the breakthrough concept of recalling and harnessing pre-existing memory immunity from childhood vaccines to treat a variety of cancers. CHIME BTx is the first corporate spin-off from La Jolla Institute for Allergy and Immunology (LJI, San Diego) in over 25 years. CHIME has obtained an exclusive license to specific intellectual property from LJI."

AimRX / EpicentRx
AIMRx / EpicentRx, a clinical stage biotechnology company, is at the forefront of the rapidly emerging field of epigenetics and has the potential to change the face of medicine. With a focus on the epicenter of life science innovation and forward-thinking leadership, EpicentRx embodies a “radical” new approach to discover and develop improved therapeutic options from non-traditional sources for unmet medical needs.

Lin Bioscience
Lin BioScience is a biotechnology company that specializes in new drug development for innovative therapeutics in diseases with unmet medical needs. Lin BioScience’s diverse and novel pipelines consist of first-in-class drug candidates aiming to treat life-threatening or disabling diseases in Oncology and Ophthalmology indications.

JLABS San Diego together with Janssen R&D

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and healthtech sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to ten global locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto, Beerse (Belgium), with New York City, opening in June 2018, and Shanghai in 2019. For more information please visit or follow @JLABS.

Event contact

Related content